GLUE
Price
$6.35
Change
-$0.12 (-1.85%)
Updated
Sep 17, 04:59 PM (EDT)
Capitalization
399.58M
49 days until earnings call
MTVA
Price
$1.07
Change
-$0.26 (-19.55%)
Updated
Sep 17, 04:59 PM (EDT)
Capitalization
25.65M
Interact to see
Advertisement

GLUE vs MTVA

Header iconGLUE vs MTVA Comparison
Open Charts GLUE vs MTVABanner chart's image
Monte Rosa Therapeutics
Price$6.35
Change-$0.12 (-1.85%)
Volume$14.33K
Capitalization399.58M
MetaVia
Price$1.07
Change-$0.26 (-19.55%)
Volume$500
Capitalization25.65M
GLUE vs MTVA Comparison Chart in %
Loading...
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLUE vs. MTVA commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLUE is a Hold and MTVA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (GLUE: $6.36 vs. MTVA: $1.06)
Brand notoriety: GLUE and MTVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLUE: 164% vs. MTVA: 70%
Market capitalization -- GLUE: $399.58M vs. MTVA: $25.65M
GLUE [@Biotechnology] is valued at $399.58M. MTVA’s [@Biotechnology] market capitalization is $25.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.34B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLUE’s FA Score shows that 0 FA rating(s) are green whileMTVA’s FA Score has 1 green FA rating(s).

  • GLUE’s FA Score: 0 green, 5 red.
  • MTVA’s FA Score: 1 green, 4 red.
According to our system of comparison, both GLUE and MTVA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLUE’s TA Score shows that 6 TA indicator(s) are bullish while MTVA’s TA Score has 6 bullish TA indicator(s).

  • GLUE’s TA Score: 6 bullish, 4 bearish.
  • MTVA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both GLUE and MTVA are a good buy in the short-term.

Price Growth

GLUE (@Biotechnology) experienced а +32.40% price change this week, while MTVA (@Biotechnology) price change was +56.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.28%. For the same industry, the average monthly price growth was +6.08%, and the average quarterly price growth was +34.58%.

Reported Earning Dates

GLUE is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+1.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLUE($400M) has a higher market cap than MTVA($25.6M). GLUE YTD gains are higher at: -8.429 vs. MTVA (-47.783). GLUE has higher annual earnings (EBITDA): 23.3M vs. MTVA (-20.01M). GLUE has more cash in the bank: 291M vs. MTVA (17.6M). MTVA has less debt than GLUE: MTVA (98K) vs GLUE (41.1M). GLUE has higher revenues than MTVA: GLUE (178M) vs MTVA (0).
GLUEMTVAGLUE / MTVA
Capitalization400M25.6M1,563%
EBITDA23.3M-20.01M-116%
Gain YTD-8.429-47.78318%
P/E Ratio16.29N/A-
Revenue178M0-
Total Cash291M17.6M1,653%
Total Debt41.1M98K41,939%
FUNDAMENTALS RATINGS
MTVA: Fundamental Ratings
MTVA
OUTLOOK RATING
1..100
32
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLUEMTVA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 6 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 15 days ago
88%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
N/A
Bearish Trend 23 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNT20.32N/A
N/A
Verint Systems
AEIS157.81-0.22
-0.14%
Advanced Energy Industries
SNTI1.37-0.02
-1.44%
Senti Biosciences Inc.
INTC24.90-0.37
-1.46%
Intel Corp
DENN5.16-0.09
-1.71%
Denny's Corp

MTVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTVA has been loosely correlated with SPRB. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if MTVA jumps, then SPRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTVA
1D Price
Change %
MTVA100%
-20.30%
SPRB - MTVA
66%
Loosely correlated
N/A
PMVP - MTVA
35%
Loosely correlated
+4.17%
CCCC - MTVA
31%
Poorly correlated
-1.03%
KPRX - MTVA
30%
Poorly correlated
+0.57%
GLUE - MTVA
30%
Poorly correlated
-1.78%
More